This protocol is judged by an institutional assessment board, an unbiased team that evaluations any scientific trials involving people. If a review consists of a Agenda I drug, as soon as the board approves the protocol as ethical, the scientists really need to apply for an investigational new drug (IND) range from your FDA.Some scientists and cor